These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3285227)
1. Effects of thromboxane synthase inhibitors on renal function. Jackson EK; Goto F; Uderman HD; Workman RJ; Herzer WA; FitzGerald GA; Branch RA Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):183-90. PubMed ID: 3285227 [TBL] [Abstract][Full Text] [Related]
2. Effects of thromboxane synthase inhibition on vascular responsiveness in the in vivo rat mesentery. Jackson EK J Clin Invest; 1985 Dec; 76(6):2286-95. PubMed ID: 4077980 [TBL] [Abstract][Full Text] [Related]
3. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs. Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650 [TBL] [Abstract][Full Text] [Related]
4. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites. Gentilini P; Laffi G; Meacci E; La Villa G; Cominelli F; Pinzani M; Buzzelli G Gastroenterology; 1988 Jun; 94(6):1470-7. PubMed ID: 3360268 [TBL] [Abstract][Full Text] [Related]
5. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046. Hatziantoniou C; Papanikolaou N Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267 [TBL] [Abstract][Full Text] [Related]
6. The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction. Loo MH; Egan D; Vaughan ED; Marion D; Felsen D; Weisman S J Urol; 1987 Mar; 137(3):571-6. PubMed ID: 3820396 [TBL] [Abstract][Full Text] [Related]
8. Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamics in streptozotocin-induced diabetic rats. Uriu K; Kaizu K; Hashimoto O; Komine N; Etoh S Kidney Int; 1994 Mar; 45(3):794-802. PubMed ID: 8196281 [TBL] [Abstract][Full Text] [Related]
9. Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidney. Goto F; Jackson EK; Ohnishi A; Herzer W; Branch RA J Pharmacol Exp Ther; 1987 Dec; 243(3):799-803. PubMed ID: 3121844 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries. Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517 [TBL] [Abstract][Full Text] [Related]
11. Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction. Reyes AA; Klahr S Proc Soc Exp Biol Med; 1991 Oct; 198(1):572-8. PubMed ID: 1891471 [TBL] [Abstract][Full Text] [Related]
12. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis. Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320 [TBL] [Abstract][Full Text] [Related]
13. Role of thromboxane in control of arterial pressure and renal function in young spontaneously hypertensive rats. Grone HJ; Grippo RS; Arendshorst WJ; Dunn MJ Am J Physiol; 1986 Mar; 250(3 Pt 2):F488-96. PubMed ID: 3953827 [TBL] [Abstract][Full Text] [Related]
14. Thromboxane mediates renal hemodynamic response to infused angiotensin II. Wilcox CS; Welch WJ; Snellen H Kidney Int; 1991 Dec; 40(6):1090-7. PubMed ID: 1837063 [TBL] [Abstract][Full Text] [Related]
15. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets. de Chaffoy de Courcelles D; De Clerck F Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257 [TBL] [Abstract][Full Text] [Related]
16. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy. Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289 [TBL] [Abstract][Full Text] [Related]
17. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic. Welch WJ; Wilcox CS; Dunbar KR Am J Physiol; 1989 Oct; 257(4 Pt 2):F554-60. PubMed ID: 2508488 [TBL] [Abstract][Full Text] [Related]
18. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets. Watts IS; Wharton KA; White BP; Lumley P Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620 [TBL] [Abstract][Full Text] [Related]
19. Effect of thromboxane inhibition on renal blood flow in dogs with complete unilateral ureteral obstruction. Loo MH; Marion DN; Vaughan ED; Felsen D; Albanese CT J Urol; 1986 Dec; 136(6):1343-7. PubMed ID: 3464764 [TBL] [Abstract][Full Text] [Related]
20. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor. Ritter JM Br J Pharmacol; 1984 Oct; 83(2):409-18. PubMed ID: 6386089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]